| Stage | BE | % of rev | CELH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.2B | 100.00% | $847M | 100.00% | BE ×1.46 |
| Gross profit | $417M | 33.75% | $396M | 46.77% | CELH +13.0pp |
| Operating income | $225M | 18.24% | $172M | 20.31% | CELH +2.1pp |
| Pre-tax income | $250M | 20.21% | $163M | 19.25% | BE +1.0pp |
| Net income | $249M | 20.15% | $127M | 14.98% | BE +5.2pp |
| Stage | BE | CELH | Gap · A − B |
|---|---|---|---|
| Revenue | $1.2B100.00% | $847M100.00% | BE ×1.46 |
| Gross profit | 33.75%$417M | 46.77%$396M | CELH +13.0pp |
| Operating income | 18.24%$225M | 20.31%$172M | CELH +2.1pp |
| Pre-tax income | 20.21%$250M | 19.25%$163M | BE +1.0pp |
| Net income |
| 20.15%$249M |
| 14.98%$127M |
| BE +5.2pp |
No shared counterparties.